Oracle Corporation (ORCL) Stock Analysis
Latest ClaritX AI analysis ·
Oracle Corporation, a global technology giant, provides a comprehensive suite of enterprise information technology solutions worldwide. A core part of its portfolio comprises cloud-based software-as-a-service (SaaS) applications, including the Oracle Fusion Cloud suite covering enterprise resource planning (ERP), enterprise performance management (EPM), supply chain and manufacturing management (SCM), and human capital management (HCM). This also extends to specialized offerings like Oracle Advertising, the NetSuite application suite, and Oracle Fusion solutions for Sales, Service, and Marketing. Beyond these, Oracle develops cloud solutions tailored for various specific industries, alongsid
| Metric | Value |
|---|---|
| Price | $142.30 |
| Market cap | $409.9B |
| Sector | Technology |
| Industry | Software - Infrastructure |
| ClaritX AI score | 35/100 |
| Price/Book | 6.32 |
| Dividend yield | 1.41% |
| Beta | 1.73 |
AI verdict
Oracle (ORCL) continues to function as a highly speculative, debt-fueled gamble on artificial intelligence infrastructure, operating with a structurally broken technical chart and a rapidly deteriorating balance sheet. While the company is successfully securing vital enterprise partnerships, such as the recent NetApp AI storage integration, it is fundamentally failing to organically finance this massive operational pivot. The aggressive expansion into hyperscale data center construction has utterly destroyed its cash generation, resulting in a staggering Free Cash Flow deficit of -$9.68 per share. To bridge this gap, Oracle has leveraged itself to a perilous 2.335x Debt-to-Equity ratio, utilizing borrowed money to fund both its CapEx and its synthetic $2.00 per share dividend. Technically, the equity remains in a state of severe distress. Oracle is trading at a devastating 55.88% discount from its 52-week high of $322.54, burdened by immense overhead supply and resting below all critical moving averages. Compounding this structural damage, the stock carries an extremely high Beta of 1.732. While a high beta on a stock at its 52-week high can signal euphoric, market-leading momentum, a heavily indebted, fundamentally broken stock down 56% with a 1.732 beta is highly toxic. It completely lacks defensive support and remains acutely vulnerable to violent algorithmic liquidations if any macroeconomic or execution shocks occur. Rating 35/100
What this score has been worth
ClaritX scores ORCL 35 out of 100 (snapshot 2026-10-05).
Every ClaritX analysis is scored first and judged only on what the stock did afterwards. Across the 117 analyses that scored in the 0-49 band, the average forward return was -4.2% with a 32% win rate, -9.0pp against the S&P 500. That is a measured tendency across many names, not a forecast for ORCL — roughly 68% of stocks in this band still lost money.
The full band-by-band table, including the bands that lost, is on the AI Rank Report; the live strategy arms behind it are on the AI Track Record, losses published.